Back to Search
Start Over
Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop.
- Source :
-
International Forum of Allergy & Rhinology . Sep2020, Vol. 10 Issue 9, p1037-1042. 6p. - Publication Year :
- 2020
-
Abstract
- Background: Biologic medications are emerging as options for treating chronic rhinosinusitis with nasal polyps (CRSwNP). Several questions remain regarding patient selection, indications, clinical efficacy, and cost effectiveness. Methods: In November 2019, a group of physicians and scientists gathered to consider strategies for future studies regarding biologics. During the discussion, gaps in knowledge highlighted a need for a consensus on the present day use of biologics in polyp patients. Results: The goal of this guideline is to propose recommendations for the current use of biologics in CRSwNP as new evidence continues to emerge and inform practice. Conclusion: We suggest that physicians evaluate patients on an individual basis and closely monitor for improvement due to the high cost and unknown long‐term effects of biologics. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20426976
- Volume :
- 10
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- International Forum of Allergy & Rhinology
- Publication Type :
- Academic Journal
- Accession number :
- 145429290
- Full Text :
- https://doi.org/10.1002/alr.22633